RxDoctor Payments Data

Brannon Frank, MD

Interventional Pain Medicine · Austin, TXNPI 1568465763

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $4,722 of the $7,255 with a category attached, or 65.1%. 16 manufacturers reported payments, led by Boston Scientific at 41.0% of the total. That places this record below the midpoint for interventional pain medicine clinicians in TX, where the typical reported total is $6,464.

$7,255in general payments, 2019–2025

Across 148 payments — averaging $49.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$3K
  • Spinal Simplicity, LLC$1K
  • Medinc Of Texas$690
  • Abbott$686
  • Si-bone, Inc.$468
  • SPR Therapeutics, Inc$237
  • plus $854 from 10 others
$690,626in ownership & investment interests, 2019–2025

Across 7 payments — averaging $98,661 each. An ownership or investment interest held by the physician or an immediate family member.

  • Alafair Biosciences, Inc.$691K

What the payments were for

  • Travel & lodging$1,84325%
  • Food & beverage$4,72265%
  • Education$69010%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,255 in reported general payments places this provider in the 50th percentile of 287 interventional pain medicine providers in Texas.

See all interventional pain medicine providers in Texas

Medicare billing

Part B allowed, 2024
$67,046
Medicare patients
125
Services billed
629

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin29$255
Baclofen12$197

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Austin

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →